EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 210 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,515,000 | +27.9% | 167,949 | +22.8% | 0.01% | +20.0% |
Q3 2016 | $4,311,000 | +13.3% | 136,722 | +1.1% | 0.01% | 0.0% |
Q2 2016 | $3,804,000 | -13.9% | 135,260 | +11.2% | 0.01% | -16.7% |
Q1 2016 | $4,420,000 | -6.7% | 121,585 | +2.6% | 0.01% | 0.0% |
Q4 2015 | $4,739,000 | +41.8% | 118,447 | +0.9% | 0.01% | +20.0% |
Q3 2015 | $3,343,000 | -14.9% | 117,333 | -1.6% | 0.01% | 0.0% |
Q2 2015 | $3,927,000 | +27.5% | 119,181 | +11.3% | 0.01% | +25.0% |
Q1 2015 | $3,080,000 | +6.9% | 107,110 | +1.2% | 0.00% | 0.0% |
Q4 2014 | $2,882,000 | +26.1% | 105,849 | -1.3% | 0.00% | +33.3% |
Q3 2014 | $2,286,000 | -3.9% | 107,267 | +1.2% | 0.00% | 0.0% |
Q2 2014 | $2,380,000 | -11.8% | 105,956 | -0.8% | 0.00% | -25.0% |
Q1 2014 | $2,699,000 | +11.3% | 106,801 | +1.2% | 0.00% | 0.0% |
Q4 2013 | $2,425,000 | +18.8% | 105,502 | -1.6% | 0.00% | +33.3% |
Q3 2013 | $2,042,000 | +37.7% | 107,182 | +4.2% | 0.00% | 0.0% |
Q2 2013 | $1,483,000 | – | 102,874 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |